HDAC1 and glioma: In addition, many studies have shown that HDAC1 is also a good diagnostic or prognostic signature for lung cancer, gastric cancer, glioma, breast cancer, and other cancers (Cao et al., 2017; Yu et al., 2019; Guo et al., 2020; Yang et al., 2020).